Target intelligence / Profile preview

TatD DNase domain containing 2 pseudogene 2 (TATDN2P2)

Target
TATDN2P2
Molecular classification
Other (Pseudogene)
01

Overview

TatD DNase domain containing 2 pseudogene 2 (TATDN2P2) is classified as a pseudogene, which means it is a duplicate or partial copy of a protein-coding gene—in this case, related to the TatD DNase domain containing 2 gene—but has been rendered nonfunctional by disabling mutations[1][2][3]. Pseudogenes do not encode functional proteins and are traditionally considered non-functional “junk” DNA; however, emerging research indicates some pseudogenes are transcribed and can regulate their parent genes through functions at the RNA level, such as acting as decoys for microRNAs or generating regulatory non-coding RNAs[1][3]. There is no evidence that TATDN2P2 is independently functional, or that it plays a direct role in disease or is a therapeutic target. Therefore, it is not considered a receptor, enzyme, transporter, or actionable drug target.

02

Biological functions

Pseudogenes generally lack protein-coding function but may exert regulatory effects at the RNA level, such as serving as decoys for microRNAs or influencing the expression of the parent gene through RNA-based mechanisms[1][3]
03

Disease associations

Indirect or context-dependent; some pseudogenes affect cancer or other disease-relevant genes by regulating their expression or being transcriptionally active in certain tissues (e.g., cancers, testes)[1][3]. No specific evidence for TATDN2P2’s disease involvement.

Beyond the preview

Go deeper on TatD DNase domain containing 2 pseudogene 2 (TATDN2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TatD DNase domain containing 2 pseudogene 2 (TATDN2P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call